PRINCETON, NJ, USA I April 26, 2025 I UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions ...

New York University researchers say a simple, gene-based blood test has shown to be highly accurate in predicting whether ...

At the European Lung Cancer Congress (ELCC) 2025, Benjamin Besse, MD, PhD, presented a keynote talk on the rationale and strategies for treatment de-escalation in lung cancer, challenging the ...

Summary: Myriad's Precise MRD test is an ultrasensitive second-generation hybrid-capture-based tumor-informed assay that ...

Tombal believes that we can use intermittent regimens in selected patients. Perhaps there are indications based on PSA response for which patients we may be able to assess for treatment de-escalation.

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

"We are excited about the potential of BDC-3042 to help patients with cancer. This initial dose-escalation study demonstrated ...

In 2024, the Springfield Police Department employed 46 officers and received 47,945 calls for service. Of those calls, 4,113 ...

PM CDT at the ASCO Annual MeetingMIAMI, April 24, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) ...